242 related articles for article (PubMed ID: 22296667)
1. Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma.
Flood-Knapik KE; Durham AC; Gregor TP; Sánchez MD; Durney ME; Sorenmo KU
Vet Comp Oncol; 2013 Dec; 11(4):272-86. PubMed ID: 22296667
[TBL] [Abstract][Full Text] [Related]
2. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
3. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
4. Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma.
Mizutani N; Goto-Koshino Y; Takahashi M; Uchida K; Tsujimoto H
J Vet Med Sci; 2016 Sep; 78(8):1237-44. PubMed ID: 27098109
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing Intestinal Lymphoma From Inflammatory Bowel Disease in Canine Duodenal Endoscopic Biopsy Samples.
Carrasco V; Rodríguez-Bertos A; Rodríguez-Franco F; Wise AG; Maes R; Mullaney T; Kiupel M
Vet Pathol; 2015 Jul; 52(4):668-75. PubMed ID: 25487412
[TBL] [Abstract][Full Text] [Related]
6. Rectal lymphoma in 11 dogs: a retrospective study.
Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S
J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127
[TBL] [Abstract][Full Text] [Related]
7. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
[TBL] [Abstract][Full Text] [Related]
8. Canine indolent nodular lymphoma.
Valli VE; Vernau W; de Lorimier LP; Graham PS; Moore PF
Vet Pathol; 2006 May; 43(3):241-56. PubMed ID: 16672571
[TBL] [Abstract][Full Text] [Related]
9. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
Lee JJ; Hughes CS; Fine RL; Page RL
Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
[TBL] [Abstract][Full Text] [Related]
11. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
13. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.
Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ
Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.
Dhaliwal RS; Kitchell BE; Ehrhart E; Valli VE; Dervisis NG
J Am Anim Hosp Assoc; 2013; 49(3):175-84. PubMed ID: 23535752
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
Ramos-Vara JA; Miller MA; Valli VE
Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar organizing regions and Ki67 equally reflect proliferation in fine needle aspirates of normal, hyperplastic, inflamed, and neoplastic canine lymph nodes (n = 101).
Bauer NB; Zervos D; Moritz A
J Vet Intern Med; 2007; 21(5):928-35. PubMed ID: 17939545
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy.
Squire RA; Bush M; Melby EC; Neeley LM; Yarbrough B
J Natl Cancer Inst; 1973 Aug; 51(2):565-74. PubMed ID: 4765373
[No Abstract] [Full Text] [Related]
19. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
20. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.
Aresu L; Martini V; Rossi F; Vignoli M; Sampaolo M; Aricò A; Laganga P; Pierini A; Frayssinet P; Mantovani R; Marconato L
Vet Comp Oncol; 2015 Dec; 13(4):348-62. PubMed ID: 23782432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
